A British man with HIV undergoing a pioneering treatment to cure him of the disease has shown “remarkable” progress, doctors have told a newspaper. Scientists treating the 44-year-old patient are now hopeful of a breakthrough in what has been described as “one of the first serious attempts at a full cure for HIV”.
Results showed the man’s most recent blood test showed no detectable HIV was present. Results showed the man’s most recent blood test showed no detectable HIV was present. The man, who has remained anonymous, is the first of 50 people to complete a trial using the two-stage attack on the deadly virus. The research is being carried out by a collaboration of five of Britain’s top universities organised by the National Health Service. Mark Samuels, managing director of the National Institute for Health Research Office for Clinical Research Infrastructure, told the Sunday Times: “This is one of the first serious attempts at a full cure for HIV. We are exploring the real possibility of curing HIV. “This is a huge challenge and it’s still early days but the progress has been remarkable.” The trial patient told the newspaper that recent blood tests showed no detectable HIV virus was present, although it was too early to confirm that the treatment had worked. The new therapy aims to overcome a major barrier to clearing the virus from a sufferer’s body that has challenged researchers for decades. Current methods using antiretroviral therapies (Art) fall short of ridding patients of HIV, as the virus can hide out of the drugs’ reach in the immune system’s T-cells. By sheltering in dormant T-cells the virus can later take over its host and use it to produce thousands of copies of itself, should Art no longer work. The research by Oxford and Cambridge universities, Imperial College London, University College London, and King’s College London, is testing a “kick and kill” technique to first expose, then destroy the virus. First a vaccine helps the body find infected T-cells. This is then followed by a course of the drug Vorinostat that awakens the dormant T-cells, which then begin producing HIV proteins that act as a homing beacon to the immune system. Imperial College London consultant physician Professor Sarah Fidler said the treatment worked in the laboratory and there was “good evidence” it will work in patients. However she added: “We must stress we are still a long way from any actual therapy.”
360HUB IS AN ENTERTAINMENT BLOG THAT HAVE IT AS ITS PRIORITY TO SERVE YOU WELL WITH WHAT EVER YOU WISH AS LISTED ON THE HEADIES
Facebook
Subscribe to:
Post Comments (Atom)
RECOMMENDATION
POST
-
Sometimes the hardest thing about saving money is just getting started. It can be difficult to figure out simple ways to save money a...
-
You won't find any of these eats in the chip-and-dip aisle. By Emma Haak The List 1. Any and all nuts, including peanuts ...
-
This Quiz Will Reveal Your True Personality Type, According to Science Our research team recently found that a fifth-century Buddhist ...
-
2019/2020 POST-UTME EXERCISE IS HERE AGAIN A lot of people get stocked up, or confuse on the process of applying for this exercise, in t...
-
Ezeoba was appointed Chief of Naval Staff between 2012 and 2014 from his position as deputy commandant officer of the AFCSC. Dele Ezeo...
-
This is a very long letter I will encourage you to read to the end for better understanding Are you one of those who have health ch...
-
ABUJA—The Federal High Court in Abuja, yesterday, fixed April 25 to decide whether or not the detained leader of the Indigenous People of...
-
By Joseph Mmadu Date: 27/05/2019 R esearch shows that a lot of Student do there online course registration lately, some days befo...
-
By Dennis Udoma Former Governor of Akwa Ibom State, Obong Victor Attah, was in Uyo where he spoke on good governance in the count...
-
Former president-general of the Ohanaeze Ndigbo, Dr Dozie Ikedife, has invited Jewish scientists to carry out Deoxyribonucleic Acid (...
No comments:
Post a Comment